Abstract
Fourteen novel compounds were prepared and their antagonistic activities against liver X receptors (LXR) α/β were tested in vitro. Compound 26 had an IC50 value of 6.4 μM against LXRα and an IC50 value of 5.6 μM against LXRβ. Docking studies and the results of structure-activity relationships support the further development of this chemical series as LXRα/β antagonists.
Author supplied keywords
Cite
CITATION STYLE
APA
Nian, S., Gan, X., Tan, X., Yu, Z., Wang, P., Chen, X., & Wang, G. (2015). Discovery and synthesis of a novel series of liver X receptor antagonists. Chemical and Pharmaceutical Bulletin, 63(8), 628–635. https://doi.org/10.1248/cpb.c15-00261
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free